Age-related macular degeneration is associated with the HLA-cw*0701 genotype and the natural killer cell receptor AA haplotype

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 11, 2008, Pages 5077-5082

  Goverdhan, Srinivas V ^a   Khakoo, Salim I ^a   Gaston, Hannah ^b   Chen, Xiaoli ^a   Lotery, Andrew J ^a,b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; DNA; HLA C ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; CONTROL GROUP; CONTROLLED STUDY; FEMALE; GENOTYPE; HAPLOTYPE; HLA SYSTEM; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; NATURAL KILLER CELL; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; TWO TAILED TEST; COMPARATIVE STUDY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; RETINA MACULA DEGENERATION;

AGED; AGED, 80 AND OVER; ALLELES; DNA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-C ANTIGENS; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTORS, KIR;

EID: 56149112376     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-1837     Document Type: Article

References (36)

1. Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol. 1998;116:653-658. (Pubitemid 28414581)
2. Tielsch JM, Javitt JC, Coleman A, Katz J, Sommer A. The prevalence of blindness and visual impairment among nursing home residents in Baltimore. N Engl J Med. 1995;332:1205-1209.
3. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res. 2001;20:705-732.
4. Duvall J, Tso MO. Cellular mechanisms of resolution of drusen after laser coagulation: an experimental study. Arch Ophthalmol. 1985;103:694-703. (Pubitemid 15052409)
5. Killingsworth MC, Sarks JP, Sarks SH. Macrophages related to Bruch's membrane in age-related macular degeneration. Eye. 1990;4:613-621.
6. Streilein JW, Wilbanks GA, Cousins SW. Immunoregulatory mechanisms of the eye. J Neuroimmunol. 1992;39:185-200.
7. Penfold PL, Madigan MC, Gillies MC, Provis JM. Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res. 2001;20:385-414.
8. Dastgheib K, Green WR. Granulomatous reaction to Bruch's membrane in age-related macular degeneration. Arch Ophthalmol. 1994;112:813-818. (Pubitemid 24180520)
9. Penfold PL, Killingsworth MC, Sarks SH. Senile macular degeneration: the involvement of immunocompetent cells. Graefes Arch Clin Exp Ophthalmol. 1985;223:69-76. (Pubitemid 15051681)
10. Ambati J, Anand A, Fernandez S, et al. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med. 2003;9:1390-1397. (Pubitemid 37466188)
11. Baudouin C, Peyman GA, Fredj-Reygrobellet D, et al. Immunohistological study of subretinal membranes in age-related macular degeneration. Jpn J Ophthalmol. 1992;36:443-451. (Pubitemid 23035198)
12. Goverdhan SV, Howell MW, Mullins RF, et al. Association of HLA class I and class II polymorphisms with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2005;46:1726-1734. (Pubitemid 44843610)
13. Khakoo SI, Carrington M. KIR and disease: a model system or system of models? Immunol Rev. 2006;214:186-201. (Pubitemid 44707911)
14. Carrington M, Martin MP. The impact of variation at the KIR gene cluster on human disease. Curr Top Microbiol Immunol. 2006;298:225-257.
15. Mullins RF, Russell SR, Anderson DH, Hageman GS. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 2000;14:835-846.
16. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
17. Bunce M, O'Neill CM, Barnardo MC, et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens. 1995;46:355-367. (Pubitemid 26001354)
18. Bateman AC, Sage DA, al Talib RK, Theaker JM, Jones DB, Howell WM. Investigation of specimen mislabelling in paraffin-embedded tissue using a rapid, allele-specific, PCR-based HLA class II typing method. Histopathology. 1996;28:169-174.
19. Marsh SG, Parham P, Dupont B, et al. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report 2002. Hum Immunol. 2003;64:648-654. (Pubitemid 36706060)
20. Gomez-Lozano N, Vilches C. Genotyping of human killer-cell immunoglobulin-like receptor genes by polymerase chain reaction with sequence-specific primers: an update. Tissue Antigens. 2002;59:184-193. (Pubitemid 34666561)
21. Darke C, Guttridge MG, Thompson J, McNamara S, Street J, Thomas M. HLA class I (A, B) and II (DR, DQ) gene and haplotype frequencies in blood donors from Wales. Exp Clin Immunogenet. 1998;15:69-83. (Pubitemid 28334060)
22. Finch T, Lawlor E, Borton M, et al. Distribution of HLA-A, B and DR genes and haplotypes in the Irish population. Exp Clin Immunogenet. 1997;14:250-263. (Pubitemid 28075792)
23. Allele Frequencies in Worldwide Populations. http://www. allelefrequencies.net. 2006. Accessed January 3, 2008.
24. Hiby SE, Walker JJ, O'Shaughnessy KM, et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of pre-eclampsia and reproductive success. J Exp Med. 2004;200:957-965.
25. Howell WM, Calder PC, Grimble RF. Gene polymorphisms, inflammatory diseases and cancer. Proc Nutr Soc. 2002;61:447-456.
26. Thorsby E. Invited anniversary review: HLA associated diseases. Hum Immunol. 1997;53:1-11. (Pubitemid 27175988)
27. Namekawa T, Snyder MR, Yen JH, et al. Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis. J Immunol. 2000;165:1138-1145. (Pubitemid 30484786)
28. Nelson GW, Martin MP, Gladman D, Wade J, Trowsdale J, Carrington M. Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol. 2004;173:4273-4276. (Pubitemid 39280654)
29. Luszczek W, Manczak M, Cislo M, et al. Gene for the activating natural killer cell receptor, KIR2DS1, is associated with susceptibility to psoriasis vulgaris. Hum Immunol. 2004;65:758-766. (Pubitemid 39061175)
30. Dabil H, Kaplan HJ, Duffy BF, Phelan DL, Mohanakumar T, Jaramillo A. Association of the HLA-DR15/HLA-DQ6 haplotype with development of choroidal neovascular lesions in presumed ocular histoplasmosis syndrome. Hum Immunol. 2003;64:960-964. (Pubitemid 37210847)
31. van der Slik AR, Koeleman BP, Verduijn W, Bruining GJ, Roep BO, Giphart MJ. KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes. 2003;52:2639-2642. (Pubitemid 37210556)
32. Boyton RJ, Smith J, Ward R, et al. HLA-C and killer cell immunoglobulin-like receptor genes in idiopathic bronchiectasis. Am J Respir Crit Care Med. 2006;173:327-333. (Pubitemid 43209088)
33. Snyder MR, Lucas M, Vivier E, Weyand CM, Goronzy JJ. Selective activation of the c-Jun NH2-terminal protein kinase signaling pathway by stimulatory KIR in the absence of KARAP/DAP12 in CD4+ T cells. J Exp Med. 2003;197:437-449. (Pubitemid 36278600)
34. Denis L, Sivula J, Gourraud PA, et al. Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Reunion. Tissue Antigens. 2005;66:267-276. (Pubitemid 41406663)
35. Vely F, Peyrat M, Couedel C, et al. Regulation of inhibitory and activating killer-cell Ig-like receptor expression occurs in T cells after termination of TCR rearrangements. J Immunol. 2001;166:2487-2494. (Pubitemid 32173485)
36. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet. 2001;29:306-309. (Pubitemid 33096456)